Membrane vesicles in ovarian cancer fluids: A new potential marker

被引:0
|
作者
Ginestra, A
Miceli, D
Dolo, V
Romano, FM
Vittorelli, ML
机构
[1] Dipartimento Biol Cellulare & Sviluppo, I-90128 Palermo, Italy
[2] Osped M Ascoli ARNAS, Div Ginecol Oncol, Palermo, Italy
[3] Ctr Oncobiol Sperimentale, Palermo, Italy
关键词
ovarian cancer; shed vesicles; tumor progression; matrix metalloproteinases;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The rate of membrane vesicle shedding by tumor cells is probably related to their invasive capability. In order to verify whether the vesicle amount could be utilized as a marker of different pathologies, we analyzed biological fluids obtained from 33 patients with gynecological diseases. In fluids of benign serous cysts, vesicle content was extremely low; in cystoadenomas and fibromas generally it was low. On the contrary, large amounts of vesicles were found in malignant tumor fluids. Gelatin zymographies showed the presence of MMP-2 and MMP-9 in all vesicles except in those recovered from fluids of some serous cysts. A positive correlation between tumor malignancy and both vesicle-amount and vesicle-associated MMP-2 activity was noticed. We also analyzed vesicle content in ascitic fluids recovered from two carcinomas at different times during clinical treatment. In both cases, tumor progression, not monitored by Ca 125 levels, was pointed out by an increased amount of vesicles in ascites. These findings suggest that vesicle content in biological fluids could represent a new useful marker of tumor aggressiveness and tumor progression.
引用
收藏
页码:3439 / 3445
页数:7
相关论文
共 50 条
  • [41] The kallikrein proteins: New potential biomarkers for ovarian cancer
    Yousef, GM
    Katsaros, D
    Diamandis, EP
    LABORATORY INVESTIGATION, 2005, 85 : 209A - 209A
  • [42] ASPARAGINE SYNTHETASE: A NEW POTENTIAL BIOMARKER IN OVARIAN CANCER
    Lorenzi, Philip L.
    Weinstein, John N.
    DRUG NEWS & PERSPECTIVES, 2009, 22 (01) : 61 - 64
  • [43] The kallikrein proteins: New potential biomarkers for ovarian cancer
    Yousef, GM
    Katsaros, D
    Diamandis, EP
    MODERN PATHOLOGY, 2005, 18 : 209A - 209A
  • [44] Epithelial Membrane Protein 1 is a Potential Prognostic Biomarker for Ovarian Cancer
    Xie, Yongjin
    Huang, Zhen
    Chen, Zhiwei
    Lin, Yingying
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (12):
  • [45] PLACENTAL EXTRACELLULAR VESICLES COULD HAVE A THERAPEUTIC POTENTIAL ON OVARIAN CANCER BY UNIQUE MIRNAS PRESENTED IN PLACENTAL EXTRACELLULAR VESICLES
    Zhao, Min
    Sun, Xinyi
    Tang, Yunhui
    Chen, Qi
    PLACENTA, 2023, 140 : E93 - E93
  • [46] Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
    Dolo, V
    D'Ascenzo, S
    Violini, S
    Pompucci, L
    Festuccia, C
    Ginestra, A
    Vittorelli, ML
    Canevari, S
    Pavan, A
    CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (02) : 131 - 140
  • [47] Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
    Vincenza Dolo
    Sandra D'Ascenzo
    Stefania Violini
    Lorena Pompucci
    Claudio Festuccia
    Angela Ginestra
    M. Letizia Vittorelli
    Silvana Canevari
    Antonio Pavan
    Clinical & Experimental Metastasis, 1999, 17 : 131 - 140
  • [48] INHIBIN AS A MARKER FOR OVARIAN-CANCER
    COOKE, I
    OBRIEN, M
    CHARNOCK, FM
    GROOME, N
    GANESAN, TS
    BRITISH JOURNAL OF CANCER, 1995, 71 (05) : 1046 - 1050
  • [49] PANCREAS SPECIFIC ANTIGEN AS A NEW POTENTIAL MARKER FOR PANCREAS CANCER
    LOOR, R
    NOWAK, NJ
    MANZO, ML
    DOUGLASS, HO
    CHU, TM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 108 - 108
  • [50] PROSTATE ANTIGEN - A NEW POTENTIAL MARKER FOR PROSTATIC-CANCER
    WANG, MC
    PAPSIDORE, LD
    KURIYAMA, M
    VALENZUELA, LA
    MURPHY, GP
    CHU, TM
    PROSTATE, 1981, 2 (01): : 89 - 96